HANS GP HLDGS (00554) announced that on December 23, 2025, pursuant to the share option scheme adopted by the company on May 31, 2023, it granted a total of 249 million share options to Mr. Dai Wei (Chairman of the Board, Executive Director, and major shareholder) and Mr. Zhang Lei (Executive Director), collectively referred to as the grantees. The options carry the right to subscribe for an equivalent number of the company's ordinary shares. Among the granted options, 244 million shares were allocated to Mr. Dai, while 5 million shares were granted to Mr. Zhang. The options will only become effective upon acceptance by the grantees, and the grant to Mr. Dai is subject to approval by shareholders at an extraordinary general meeting.